vs
COASTAL FINANCIAL CORP（CCB）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是COASTAL FINANCIAL CORP的1.4倍（$197.9M vs $138.0M），REPLIGEN CORP同比增速更快（13.6% vs -5.8%），COASTAL FINANCIAL CORP自由现金流更多（$246.1M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -3.6%）
富达国民金融是美国财富500强企业，面向房地产与按揭行业提供产权保险及交割服务。2019年，其产权及房地产业务相关年营收约为84.69亿美元，是行业内具有领先地位的金融服务提供商。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CCB vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.4倍
$138.0M
营收增速更快
RGEN
高出19.4%
-5.8%
自由现金流更多
CCB
多$228.6M
$17.6M
两年增速更快
RGEN
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $138.0M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 12.4% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | -5.8% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $0.84 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCBRGEN
| Q4 25 | $138.0M | $197.9M | ||
| Q3 25 | $144.7M | $188.8M | ||
| Q2 25 | $119.4M | $182.4M | ||
| Q1 25 | $139.5M | $169.2M | ||
| Q4 24 | $146.5M | $174.1M | ||
| Q3 24 | $151.1M | $154.9M | ||
| Q2 24 | $135.3M | $154.1M | ||
| Q1 24 | $148.4M | $151.3M |
净利润CCBRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $13.6M | $14.9M | ||
| Q2 25 | $11.0M | $14.9M | ||
| Q1 25 | $9.7M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $13.5M | $-654.0K | ||
| Q2 24 | $11.6M | $3.3M | ||
| Q1 24 | $6.8M | $2.1M |
毛利率CCBRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率CCBRGEN
| Q4 25 | 12.4% | 9.0% | ||
| Q3 25 | 12.4% | 8.9% | ||
| Q2 25 | 12.0% | 7.6% | ||
| Q1 25 | 8.4% | 3.9% | ||
| Q4 24 | 11.7% | -17.7% | ||
| Q3 24 | 10.8% | -5.1% | ||
| Q2 24 | 11.1% | 1.0% | ||
| Q1 24 | 5.9% | 1.3% |
净利率CCBRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | 9.4% | 7.9% | ||
| Q2 25 | 9.2% | 8.2% | ||
| Q1 25 | 7.0% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 8.9% | -0.4% | ||
| Q2 24 | 8.6% | 2.2% | ||
| Q1 24 | 4.6% | 1.4% |
每股收益（稀释后）CCBRGEN
| Q4 25 | $0.84 | $0.24 | ||
| Q3 25 | $0.88 | $0.26 | ||
| Q2 25 | $0.71 | $0.26 | ||
| Q1 25 | $0.63 | $0.10 | ||
| Q4 24 | $0.95 | $-0.55 | ||
| Q3 24 | $0.97 | $-0.01 | ||
| Q2 24 | $0.84 | $0.06 | ||
| Q1 24 | $0.50 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $491.0M | $2.1B |
| 总资产 | $4.7B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CCBRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务CCBRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CCBRGEN
| Q4 25 | $491.0M | $2.1B | ||
| Q3 25 | $475.3M | $2.1B | ||
| Q2 25 | $461.7M | $2.1B | ||
| Q1 25 | $449.9M | $2.0B | ||
| Q4 24 | $438.7M | $2.0B | ||
| Q3 24 | $331.9M | $2.0B | ||
| Q2 24 | $316.7M | $2.0B | ||
| Q1 24 | $303.7M | $2.0B |
总资产CCBRGEN
| Q4 25 | $4.7B | $2.9B | ||
| Q3 25 | $4.6B | $2.9B | ||
| Q2 25 | $4.5B | $2.9B | ||
| Q1 25 | $4.3B | $2.9B | ||
| Q4 24 | $4.1B | $2.8B | ||
| Q3 24 | $4.1B | $2.8B | ||
| Q2 24 | $4.0B | $2.9B | ||
| Q1 24 | $3.9B | $2.8B |
负债/权益比CCBRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $254.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $246.1M | $17.6M |
| 自由现金流率自由现金流/营收 | 178.3% | 8.9% |
| 资本支出强度资本支出/营收 | 6.1% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $436.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流CCBRGEN
| Q4 25 | $254.6M | $25.7M | ||
| Q3 25 | $59.0M | $48.1M | ||
| Q2 25 | $66.0M | $28.6M | ||
| Q1 25 | $71.7M | $15.0M | ||
| Q4 24 | $259.8M | $39.2M | ||
| Q3 24 | $62.6M | $49.3M | ||
| Q2 24 | $72.1M | $42.2M | ||
| Q1 24 | $56.8M | $44.7M |
自由现金流CCBRGEN
| Q4 25 | $246.1M | $17.6M | ||
| Q3 25 | $57.4M | $43.4M | ||
| Q2 25 | $64.0M | $21.5M | ||
| Q1 25 | $68.9M | $11.4M | ||
| Q4 24 | $249.9M | $33.6M | ||
| Q3 24 | $60.2M | $42.3M | ||
| Q2 24 | $69.5M | $37.4M | ||
| Q1 24 | $55.0M | $36.4M |
自由现金流率CCBRGEN
| Q4 25 | 178.3% | 8.9% | ||
| Q3 25 | 39.7% | 23.0% | ||
| Q2 25 | 53.6% | 11.8% | ||
| Q1 25 | 49.4% | 6.8% | ||
| Q4 24 | 170.6% | 19.3% | ||
| Q3 24 | 39.8% | 27.3% | ||
| Q2 24 | 51.3% | 24.3% | ||
| Q1 24 | 37.1% | 24.0% |
资本支出强度CCBRGEN
| Q4 25 | 6.1% | 4.1% | ||
| Q3 25 | 1.2% | 2.5% | ||
| Q2 25 | 1.7% | 3.9% | ||
| Q1 25 | 2.0% | 2.1% | ||
| Q4 24 | 6.8% | 3.2% | ||
| Q3 24 | 1.6% | 4.5% | ||
| Q2 24 | 1.9% | 3.1% | ||
| Q1 24 | 1.2% | 5.5% |
现金转化率CCBRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 4.34× | 3.23× | ||
| Q2 25 | 5.99× | 1.92× | ||
| Q1 25 | 7.37× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.65× | — | ||
| Q2 24 | 6.22× | 12.70× | ||
| Q1 24 | 8.35× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCB
| Other | $74.7M | 54% |
| Baa S Credit Enhancements | $47.3M | 34% |
| Baa S Program Income | $8.4M | 6% |
| Transaction Fees | $4.9M | 4% |
| Servicing And Other Baa S Fees | $1.6M | 1% |
| Baa S Fraud Enhancements | $1.1M | 1% |
RGEN
暂无分部数据
